Asiakirja-aineiston arvioinnin tila

ECHA’s dossier evaluation process covers compliance checks and the examination of testing proposals. By consulting the table below, you can find out whether ECHA has started to evaluate dossiers for a particular substance and follow the progress through the evaluation process.

The table below displays the type, scope and status of the assessment undertaken for a given dossier. The decision date and the non-confidential version of the decision are published shortly after the decision has been adopted.

Before publishing the non-confidential version of an adopted decision on its website, ECHA consults the addressees of the decision on this version. ECHA systematically removes any personal data from the non-confidential version of a decision. Some sections may also be redacted based on justified claims by registrants, regarding information confidential or deemed to harm their commercial interest if disclosed.

Check the expandable boxes below for more details.

Content of the table

Identifiers of the substance: Name (as on the Dissemination website); EC/List number (European Community number / List number assigned by ECHA); CAS number (also called the Chemical Abstract Service Registry Number or CAS RN).

Decision type can be ‘CCH’ for Compliance Check Evaluation and ‘TPE’ for Testing Proposal Evaluation.

Scope refers to the scope of the evaluation and can be:

Targeted: The compliance check focuses only on some endpoints.
Comprehensive: The compliance check focuses on all relevant endpoints under ECHA’s strategy.
Testing proposal: The assessment focuses on the testing proposals submitted by the registrants.

Status reports the current position of the dossier in the dossier evaluation process and can be:

Under assessment: The evaluation of the dossier has formally started.
Ongoing: The registrants have received the draft decision - The dossier retains this status until the decision is adopted or the evaluation is otherwise concluded.
Information requested: The registrants have received the adopted decision with the deadline for providing the requested information.
Follow-up: The deadline set in the adopted decision has passed, and ECHA is assessing whether the information requested in the decision has been provided in the dossier update - This follow-up may also involve the national enforcement authorities.
Concluded: The evaluation is closed.
In most cases, this means that the registrant has responded to the adopted decision with compliant information. However, as in some cases an evaluation is concluded at an earlier stage, an adopted decision is not always available for every evaluation marked as concluded.

Decision date reports the date on which the adopted decision was sent to the registrants.

Decision displays a non-confidential version of the adopted decision once available.

Latest update indicates the date of the latest automatic update carried out by ECHA’s information systems.

You can access the disseminated registration dossier, available in the ‘Registered substances’ section of ECHA’s website, by clicking on the magnifying glass icon. Except when confidentiality is claimed on the substance identifiers, the adopted decision is directly linked to the disseminated dossier.

You can access additional information in ‘Details’ view, by clicking on the eye icon:

Substance identifiers
Decision type (CCH or TPE), scope and status of the evaluation, as in the main table
Decision’s deadline(s): The deadline(s) for requested information contained in the decision, should the decision contain more than one deadline
Appeal information: If the registrants have appealed against the adopted decision, a link to the Board of Appeal’s announcement document is provided.

How to read the table

ECHA’s information systems automatically update the status of dossier evaluations during the process. For transparency reasons, all dossier evaluation decisions will remain published. This also applies if the registrants have appealed or have updated the registration dossier as requested in the decision.

It is for the reader to verify the status of an evaluation: check the deadline of the decision, the indicated status of the evaluation, and the content of the registration dossier. The most recent data on a substance is available in the ‘Registered substances’ section of ECHA’s website; check also whether the Board of Appeal has taken a decision regarding any appeal.

Important notes:

The dossier evaluation decisions may not apply to all registrants that are part of a joint registration.
There may be a delay between the decision date and the actual publication of the adopted decision, which corresponds to the consultation on its non-confidential version and addressing any comments from the registrants.
The information in the disseminated registration dossier is obtained from all registration dossiers which are part of the joint submission of a substance, including the names of the registrants, unless claimed confidential.

Last updated 01 kesäkuuta 2023. Database contains 3944 unique substances/entries.

Filter the list

Substance Identifier

Decision type:

Scope

Decision's deadline:

Status:

Decision date:

Näyttää 1 – 50 yhteensä 7 171 tuloksesta.

Substance name	EC / List no	CAS no	Decision type	Scope	Status	Decision date	Decision	Latest update
Trometamol	201-064-4	77-86-1	CCH	Targeted	Information requested	14-huhtikuuta-2023	CCH-D-2114633420-62-01/F	01-kesäkuuta-2023	Details
Triisotridecyl benzene-1,2,4-tricarboxylate	276-594-2	72361-35-4	CCH	Comprehensive	Follow-up	19-elokuuta-2020	CCH-D-2114517048-53-01/F	01-kesäkuuta-2023	Details
Triisodecyl benzene-1,2,4-tricarboxylate	253-138-0	36631-30-8	CCH	Comprehensive	Follow-up	19-elokuuta-2020	CCH-D-2114517058-52-01/F	01-kesäkuuta-2023	Details
Tall oil, maleated	268-859-6	68152-93-2	CCH	Comprehensive	Concluded	13-joulukuuta-2019	CCH-D-2114493717-33-01/F	01-kesäkuuta-2023	Details
Sodium salts of [[(phosphonomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonic acid (5-7 Na:1)	701-216-4	-	CCH	Comprehensive	Follow-up	14-helmikuuta-2020	CCH-D-2114495836-29-01/F	01-kesäkuuta-2023	Details
Sodium salts of [[(phosphonomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonic acid (1-3 Na:1)	701-215-9	-	CCH	Comprehensive	Follow-up	14-helmikuuta-2020	CCH-D-2114495769-22-01/F	01-kesäkuuta-2023	Details
Sodium hydroxymethanesulphinate	205-739-4	149-44-0	CCH	Comprehensive	Concluded	10-marraskuuta-2017		01-kesäkuuta-2023	Details
Pyridinium, 1-[2-[[4-[[3-[2-[6-amino-1-hydroxy-3-sulfo-5-[2-[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-2-naphthalenyl]diazenyl]-4-sulfophenyl]amino]-4-oxobutyl]sulfonyl]ethyl]-3-carboxy-, inner salt, sodium salt (1:4)	855-027-8	2409921-75-9	CCH	Comprehensive	Information requested	14-huhtikuuta-2023	CCH-D-2114633798-33-01/F	01-kesäkuuta-2023	Details
Pentasodium pentahydrogen [[(phosphonatomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate	263-212-4	61792-09-4	CCH	Comprehensive	Follow-up	14-helmikuuta-2020	CCH-D-2114499240-48-01/F	01-kesäkuuta-2023	Details
Oxirane, 2,2'-[cyclohexylidenebis(4,1-phenyleneoxymethylene)]bis-	810-464-3	13446-84-9	CCH	Comprehensive	Follow-up	15-marraskuuta-2021	CCH-D-2114575385-39-01/F	01-kesäkuuta-2023	Details
N-pentan-2-ylidenehydroxylamine	484-470-6	623-40-5	TPE	Testing Proposal	Follow-up	17-helmikuuta-2022	TPE-D-2114586236-41-01/F	01-kesäkuuta-2023	Details
N-pentan-2-ylidenehydroxylamine	484-470-6	623-40-5	TPE	Testing Proposal	Follow-up	17-helmikuuta-2022	TPE-D-2114586233-47-01/F	01-kesäkuuta-2023	Details
Morpholine, 4-C12-14-alkyl derivs.	800-906-3	1402434-48-3	CCH	Comprehensive	Information requested	14-huhtikuuta-2023	CCH-D-2114633935-41-01/F	01-kesäkuuta-2023	Details
Hexanal	200-624-5	66-25-1	TPE	Testing Proposal	Follow-up	14-huhtikuuta-2023	TPE-D-2114633963-42-01/F	01-kesäkuuta-2023	Details
Chrome antimony titanium buff rutile This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77310.	269-052-1	68186-90-3	CCH	Comprehensive	Follow-up	14-elokuuta-2020	CCH-D-2114520292-61-01/F	01-kesäkuuta-2023	Details
[No public or meaningful name is available]	-	-	TPE	Testing Proposal	Concluded	11-maaliskuuta-2020	TPE-D-2114501197-56-01/F	01-kesäkuuta-2023	Details
[[(phosphonomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonic acid	239-931-4	15827-60-8	CCH	Comprehensive	Follow-up	14-helmikuuta-2020	CCH-D-2114495838-25-01/F	01-kesäkuuta-2023	Details
6-(cyclohexylamino)-3-methyl-3H-dibenz[f,ij]isoquinoline-2,7-dione	244-320-0	21295-57-8	TPE	Testing Proposal	Information requested	14-huhtikuuta-2023	TPE-D-2114633159-47-01/F	01-kesäkuuta-2023	Details
5,5'-(1H-isoindole-1,3(2H)-diylidene)dibarbituric acid	253-256-2	36888-99-0	CCH	Comprehensive	Follow-up	12-elokuuta-2020	CCH-D-2114509762-49-01/F	01-kesäkuuta-2023	Details
4-[(morpholinothio)thioxomethyl]morpholine	237-335-9	13752-51-7	CCH	Comprehensive	Information requested	14-huhtikuuta-2023	CCH-D-2114633937-37-01/F	01-kesäkuuta-2023	Details
4,4'-cyclohexylidenedi-o-cresol	219-110-7	2362-14-3	CCH	Comprehensive	Follow-up	15-marraskuuta-2021	CCH-D-2114575394-40-01/F	01-kesäkuuta-2023	Details
2-cyano-2-[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-N-methylacetamide	278-388-8	76199-85-4	CCH	Comprehensive	Follow-up	12-elokuuta-2020	CCH-D-2114509771-50-01/F	01-kesäkuuta-2023	Details
2-amino-2-ethylpropanediol	204-101-2	115-70-8	CCH	Targeted	Information requested	14-huhtikuuta-2023	CCH-D-2114633425-52-01/F	01-kesäkuuta-2023	Details
2,3-epoxypropyl neodecanoate	247-979-2	26761-45-5	TPE	Testing Proposal	Follow-up	19-elokuuta-2021	TPE-D-2114565639-32-01/F	01-kesäkuuta-2023	Details
1-isopropyl-2,2-dimethyltrimethylene diisobutyrate	229-934-9	6846-50-0	CCH	Comprehensive	Follow-up	14-elokuuta-2020	CCH-D-2114519435-50-01/F	01-kesäkuuta-2023	Details
1,2,4-Benzenetricarboxylic acid, mixed decyl and octyl triesters	290-754-9	90218-76-1	CCH	Comprehensive	Follow-up	19-elokuuta-2020	CCH-D-2114517040-69-01/F	01-kesäkuuta-2023	Details
COASOL 290 PLUS	-	-	TPE	Testing Proposal	Concluded			31-toukokuuta-2023	Details
γ-butyrolactone	202-509-5	96-48-0	CCH	Comprehensive	Information requested	26-toukokuuta-2023		29-toukokuuta-2023	Details
Tetrabromophthalic anhydride	211-185-4	632-79-1	CCH	Comprehensive	Information requested	26-toukokuuta-2023		29-toukokuuta-2023	Details
Hexadecyltrimethoxysilane	240-464-3	16415-12-6	TPE	Testing Proposal	Ongoing			29-toukokuuta-2023	Details
Fatty acids, C16-18, isononyl esters	292-960-4	91031-57-1	TPE	Testing Proposal	Under assessment			29-toukokuuta-2023	Details
Dimethyl propylphosphonate	242-555-3	18755-43-6	CCH	Comprehensive	Concluded			29-toukokuuta-2023	Details
di-p-tolyl(2,4,6-trimethylbenzoyl)phosphine oxide	884-585-5	270586-78-2	TPE	Testing Proposal	Under assessment			29-toukokuuta-2023	Details
4,4'-Isopropylidenedicyclohexanol, oligomeric reaction products with 1-chloro-2,3-epoxypropane	500-070-7	30583-72-3	CCH	Comprehensive	Information requested	26-toukokuuta-2023		29-toukokuuta-2023	Details
2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, reaction products with phosphorus oxide	810-703-1	1187441-10-6	CCH	Comprehensive	Information requested	26-toukokuuta-2023		29-toukokuuta-2023	Details
2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, reaction products with phosphorus oxide	810-703-1	1187441-10-6	CCH	Comprehensive	Information requested	26-toukokuuta-2023		29-toukokuuta-2023	Details
2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, reaction products with phosphorus oxide	810-703-1	1187441-10-6	TPE	Testing Proposal	Information requested	26-toukokuuta-2023		29-toukokuuta-2023	Details
1,2,3,5,6,7-hexahydro-1,1,2,3,3-pentamethyl-4H-inden-4-one	251-649-3	33704-61-9	TPE	Testing Proposal	Under assessment			29-toukokuuta-2023	Details
Tetramethylammonium hydroxide	200-882-9	75-59-2	TPE	Testing Proposal	Under assessment			26-toukokuuta-2023	Details
Resin acids and Rosin acids, Me esters	269-035-9	68186-14-1	TPE	Testing Proposal				26-toukokuuta-2023	Details
Reaction Products Of Dimethyl Hydrogen Phosphite And Alcohols C14-18, Even, Linear	944-574-9	-	CCH	Comprehensive	Information requested	24-toukokuuta-2023		26-toukokuuta-2023	Details
Octylphosphonic acid	225-218-5	4724-48-5	CCH	Comprehensive	Information requested	24-toukokuuta-2023		26-toukokuuta-2023	Details
Ethyldimethyl[2-[(2-methyl-1-oxoallyl)oxy]ethyl]ammonium ethyl sulphate	236-195-6	13223-03-5	CCH	Comprehensive	Information requested	25-toukokuuta-2023		26-toukokuuta-2023	Details
Cyclohex-1,2-ylenediamine	211-776-7	694-83-7	CCH	Targeted	Information requested	24-toukokuuta-2023		26-toukokuuta-2023	Details
Benzyldimethyl[2-[(1-oxoallyl)oxy]ethyl]ammonium chloride	256-283-8	46830-22-2	CCH	Comprehensive	Information requested	25-toukokuuta-2023		26-toukokuuta-2023	Details
[2-(methacryloyloxy)ethyl]trimethylammonium chloride	225-733-5	5039-78-1	CCH	Comprehensive	Information requested	25-toukokuuta-2023		26-toukokuuta-2023	Details
[2-(acryloyloxy)ethyl]trimethylammonium chloride	256-176-6	44992-01-0	CCH	Comprehensive	Information requested	25-toukokuuta-2023		26-toukokuuta-2023	Details
2-(dimethylamino)ethyl acrylate	219-460-0	2439-35-2	CCH	Comprehensive	Information requested	25-toukokuuta-2023		26-toukokuuta-2023	Details
Vinyl ethylene carbonate	700-261-7	4427-96-7	TPE	Testing Proposal	Under assessment			24-toukokuuta-2023	Details
Tetradec-1-ene, dimers, hydrogenated	701-321-5	-	TPE	Testing Proposal				24-toukokuuta-2023	Details

Näyttää 1 – 50 yhteensä 7 171 tuloksesta.

Export search results to:

EU Privacy Disclaimer

Tällä verkkosivustolla käytetään evästeitä parhaan mahdollisen käyttäjäkokemuksen varmistamiseksi.

Lue lisää

EU Privacy Disclaimer

Asiakirja-aineiston arvioinnin tila

Asiakirja-aineiston arvioinnin tila

Asiakirja-aineiston arvioinnin tila

Further information

See a problem or have feedback?

Last updated 01 kesäkuuta 2023. Database contains 3944 unique substances/entries.

EU Privacy Disclaimer